Company
LON:BMK
Benchmark Holdings PLC is a market leading aquaculture biotechnology company. The company's mission is to drive sustainability in aquaculture by delivering mission critical products and solutions that improve farming efficiency and animal health and welfare for aquaculture producers. Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species in all the major aquaculture regions around the world.
110 stories · page 2 of 6
Archive
3 May 2022*A corporate client of Hybridan LLPDish of the dayJoiners:No Joiners Today.Leavers:Harrogate Group has left the Aquis Growth Market.What’s cooking in the IPO kitchen?LON:ANR, the AQSE listed mining exploration company focused on t
Granting of the marketing authorisation variation also represents a step towards optimising the efficiency of the company's sea lice solution
The aquaculture biotechnology business said there is a positive market environment across its core species
Aim-listed group is raising £20.7mln through a placing at 62p
Advanced Nutrition has been the stand-out performer
The CleanTreat technology won the highest possible mark awarded by the Aquaculture Stewardship Council
The group has seen some recovery from COVID-19 in its end markets, particularly in shrimp, as lockdown restrictions ease and the hospitality sector reopens
Marketing authorisation represents 'a major milestone for the company'
Significant progress was made towards commercialisation of the new sea lice treatment BMK08 and CleanTreat
The commercial launch remains subject to the grant of a Marketing Authorisation in Norway.
The aquaculture firm said the deals secure customer access to one of its CleanTreat units which will be deployed in conjunction with the new sea lice treatment BMK08
The aquaculture specialist partially attributed the improved performance to a 32% jump in revenues from its Advanced Nutrition business following what it said was “slight improvement in certain markets” where COVID-19 restrictions have ease
On the trading front, the picture in the fiscal fourth-quarter (Q4) was much the same as in Q3, with the shrimp markets having a tough time while salmon markets were relatively stable
The aquaculture biotechnology business noted that this is an important step towards the launch of BMK08 together with the company's water purification system CleanTreat in the second quarter of its financial year to end-September 2021
The aquaculture group said the genetics business had seen “continued good performance” in the quarter
The company has sold the Braintree facility to Cell and Gene Therapy Catapult for £16mln
The group's facility in Braintree will be sold to Cell and Gene Therapy Catapult for £16mln in cash
The aquaculture firm has sold the business to a subsidiary of Zoetis, the world's largest producer of medicine and vaccinations for pets and livestock
The aquaculture firm said it will receive up to £12.75mln from the sale of Improve to three of its directors alongside private equity firm RJD Partners
"Our salmon business has been more robust in the face of the global lockdown with good visibility, and this, together with a solid cash position after our fundraising in February and our cash conservation plan, gives us confidence in managi
